×
About 46,550 results

Standard Operating Procedure (SOP) for Triage of Suspected COVID-19 Patients in non-US Healthcare Settings: Early Identification and Prevention of Transmission during Triage | CDC
https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/sop-triage-prevent-transmission.html

Jul 14th, 2022 - Summary of Recent Changes. Updates as of July 14, 2021 Minor revisions to improve clarity and flow of guidance. Key Points: Early identification and separation of suspected COVID-19 patients at triage is important to prevent transmission in healthcare facilities. Healthcare facility administrators need to provide public and patients with information on COVID-19 prevention measures before and up...

Management of Visitors to Healthcare Facilities in the Context of COVID-19: Non-US Healthcare Settings | CDC
https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/hcf-visitors.html

Jul 14th, 2022 - The Centers for Disease Control and Prevention (CDC) is working closely with international partners to respond to the coronavirus (COVID-19) pandemic. CDC provides technical assistance to help other countries increase their ability to prevent, detect, and respond to health threats, including COVID-19. This document is provided by CDC and is intended for use in non-US healthcare settings. Traini...

It Starts at the Beginning: Racism in the Medical Profession
https://www.medscape.com/viewarticle/975309

Jun 15th, 2022 - It makes sense for me to start my blogging journey from the beginning. When I was an undergrad, my premed advisor told me there would be no point in me applying to medical school because my grades were too low. This comment came after making high marks in his cell biology class, a result of finally learning how to regurgitate large amounts of information. College had been an uphill struggle of ...

Crohn's Disease Biomarker Appears Years Ahead of Diagnosis
https://www.medscape.com/viewarticle/975081

Jun 6th, 2022 - Anti–granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibodies predict complicated Crohn's disease (CD) years before signs or symptoms of the disease appear, according to new data. A study of records from active military personnel indicates that this novel biomarker holds promise for the diagnosis, management, and treatment of complicated CD. "To the best of my knowledge, this is...

Spell It Out: Writing Out Common Medical Terms Boosts Patient Understanding, Says Study
https://www.medscape.com/viewarticle/974030

May 16th, 2022 - MI. HTN. hx. Although these abbreviations might make it easier for physicians and other healthcare professionals to create and consume clinical documentation, the shorthand confuses patients, according to a study published May 13 in JAMA Network Open. Researchers, who conducted clinical trials at three hospitals, found that expansion of 10 common medical abbreviations and acronyms in patient he...

More than half of Americans have had COVID infections -U.S. study
https://www.reuters.com/article/us-health-coronavirus-usa/more-than-half-of-americans-have-had-covid-infections-u-s-study-idUSKCN2MI1PE

Apr 27th, 2022 - (Reuters) -Following the record surge in COVID-19 cases during the Omicron-driven wave, some 58% of the U.S. population overall and more than 75% of younger children have been infected with the coronavirus since the start of the pandemic, according to a U.S. nationwide blood survey released on Tuesday. The study issued by the U.S. Centers for Disease Control (CDC) and Prevention marks the first...

J&J sues to block sales of 'dangerous' counterfeit HIV drugs
https://www.reuters.com/article/johnsonjohnson-hiv/jj-sues-to-block-sales-of-dangerous-counterfeit-hiv-drugs-idUSL2N2WO352

Apr 26th, 2022 - (Reuters) - Johnson & Johnson has filed a lawsuit against drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, months after a similar case brought by Gilead Sciences Inc. In a complaint filed April 7 and made public on Tuesday, J&J said it had learned of widespread counterfeiting through complaints from patients who received the wrong pills in thei...

Chipotle forecasts quarterly sales above Wall Street expectations
https://www.reuters.com/article/chipotle-results/chipotle-forecasts-quarterly-sales-above-wall-street-expectations-idUSL3N2WO3XT

Apr 26th, 2022 - April 26 (Reuters) - Chipotle Mexican Grill Inc forecast second-quarter same-store sales above analysts’ estimates on Tuesday, betting demand for its burritos and rice bowls will remain buoyant despite a few rounds of price increases. The burrito chain forecast comparable restaurant sales growth of 10% to 12% for the second quarter, compared with estimates of an 8.8% growth, according to IBES d...

PREVIEW-Teladoc's mental health unit in focus as cost concerns mount
https://www.reuters.com/article/teladoc-health-results-preview/preview-teladocs-mental-health-unit-in-focus-as-cost-concerns-mount-idUSL3N2WM0B8

Apr 26th, 2022

EXCLUSIVE-EU to move away from emergency phase of COVID pandemic - document
https://www.reuters.com/article/health-coronavirus-eu-pandemic/exclusive-eu-to-move-away-from-emergency-phase-of-covid-pandemic-document-idUSL2N2WO1MN

Apr 26th, 2022 - BRUSSELS, April 26 (Reuters) - The European Commission is set to say the EU has entered a new post-emergency phase of the pandemic in which testing should be targeted and monitoring of COVID-19 cases should be similar to sample-based flu surveillance, according to a draft document seen by Reuters. The shift comes amid a gradual drop of cases and a fall in the number of deaths linked to COVID-19...

3M quarterly adjusted profit falls as mask demand slumps
https://www.reuters.com/article/3m-results/3m-quarterly-adjusted-profit-falls-as-mask-demand-slumps-idUSL3N2WO249

Apr 26th, 2022 - April 26 (Reuters) - Industrial giant 3M Co reported a fall in quarterly adjusted profit on Tuesday, driven by waning demand for its disposable N95 masks as COVID-19 recedes. Adjusted earnings per share fell to $2.65 in the first quarter from $2.95 a year earlier. (Reporting by Aishwarya Nair in Bengaluru; Editing by Maju Samuel)

UPDATE 2-French care homes firm Orpea delays annual report as it faces probes
https://www.reuters.com/article/orpea-accounts/update-2-french-care-homes-firm-orpea-delays-annual-report-as-it-faces-probes-idUSL2N2WO0DF

Apr 26th, 2022 - * Shares fall, down around 60% since start of 2022 * Probes over how it runs its centre and treats residents * Q1 revenues now due on May 13 vs earlier May 3 date (Adds share price) PARIS, April 26 (Reuters) - French care homes company Orpea , which has faced investigations into how it runs its centres and treats its residents, said on Tuesday it has decided to postpone the publication of its a...

UPDATE 2-Medical gear maker Getinge's profit falls on supply chain trouble
https://www.reuters.com/article/getinge-results/update-2-medical-gear-maker-getinges-profit-falls-on-supply-chain-trouble-idUSL5N2WO1PP

Apr 26th, 2022 - (Adds detail on business in Russia, background, shares) STOCKHOLM, April 26 (Reuters) - Swedish medical equipment maker Getinge reported on Tuesday a larger than expected drop in quarterly profit due to shortages of materials and higher component costs, sending its shares down 14% in early trade. But the maker of products used in surgery, intensive care and sterilisation predicted a strong marg...

French care homes firm Orpea delays annual report as it faces probes
https://www.reuters.com/article/orpea-accounts/french-care-homes-firm-orpea-delays-annual-report-as-it-faces-probes-idUSASM0008XI

Apr 26th, 2022 - PARIS, April 26 (Reuters) - French care homes company Orpea , which has faced probes into how it runs its centres and treats its residents, said it had decided to postpone the publication of its annual accounts. It said it would delay publication to May 13 “due to the exceptional circumstances currently faced by the company, which have required the support of the teams to the investigations of ...

Taiwan clears foreign brokers of inappropriate TSMC research reports
https://www.reuters.com/article/taiwan-markets-tsmc/taiwan-clears-foreign-brokers-of-inappropriate-tsmc-research-reports-idUSL2N2WN05C

Apr 25th, 2022 - TAIPEI, April 25 (Reuters) - Taiwan’s financial regulator has cleared foreign brokers of behaving inappropriately with analyst reports on chip maker TSMC after lawmakers questioned whether they were making buy recommendations but actually selling the stock. A Financial Supervisory Commission official told Reuters they had sent questionnaires to brokerages about their analyst reports on Taiwan S...

Warehousing firm Segro flags supply chain and cost pressures amid Ukraine war
https://www.reuters.com/article/segro-outlook/warehousing-firm-segro-flags-supply-chain-and-cost-pressures-amid-ukraine-war-idUSL3N2WJ17N

Apr 21st, 2022 - April 21 (Reuters) - Segro Plc said on Thursday the Russia-Ukraine crisis would increase pressure in its construction supply chain and costs as the warehousing specialist flagged rental levels to grow across the group’s portfolio. Supply chain concerns and inflationary pressures would further “tighten the supply-demand imbalance” for its industrial assets, placing more upward pressure on rents,...

UPDATE 1-Sartorius sticks to 2022 outlook despite rising costs, Ukraine
https://www.reuters.com/article/sartorius-results/update-1-sartorius-sticks-to-2022-outlook-despite-rising-costs-ukraine-idUSL2N2WJ097

Apr 21st, 2022 - (Adds detail, background) FRANKFURT, April 21 (Reuters) - Franco-German lab supplies group Sartorius AG stuck to its 2022 outlook on Thursday as demand remained strong in the first quarter despite uncertainties from the war in Ukraine. Sartorius, which competes in bioreactor gear with Merck KGaA and Thermo Fisher, said underlying earnings before interest, taxes, depreciation and amortisation (E...

Sartorius confirms 2022 outlook as pandemic effects, order intake normalise
https://www.reuters.com/article/sartorius-results/sartorius-confirms-2022-outlook-as-pandemic-effects-order-intake-normalise-idUSL5N2WI20C

Apr 21st, 2022 - FRANKFURT, April 21 (Reuters) - Franco-German lab supplies group Sartorius AG confirmed its 2022 outlook on Thursday as pandemic-related effects and the development of order intake were normalising as expected in the first quarter. Sartorius, which competes in bioreactor gear with Merck KGaA and Thermo Fisher, said underlying earnings before interest, taxes, depreciation and amortisation (EBITD...

Alabama settles opioid claims with J&J, McKesson, Endo for $276 million -attorney general
https://www.reuters.com/article/usa-opioids-alabama/update-4-alabama-settles-opioid-claims-with-jj-mckesson-endo-for-276-mln-attorney-general-idUSL2N2WH1IV

Apr 20th, 2022 - (Reuters) -Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson, McKesson Corp and Endo International Plc, resolving claims that the companies fueled an opioid addiction crisis, the state attorney general said. Under the settlement, drug distributor McKesson will pay $141 million toward the state’s efforts to combat the opioid crisis, while drugmakers Johnson & Johnson ...

Alabama settles opioid claims against J&J, distributors for $276 mln - attorney general
https://www.reuters.com/article/usa-opioids-alabama/alabama-settles-opioid-claims-against-jj-distributors-for-276-mln-attorney-general-idUSL2N2WH1HB

Apr 19th, 2022 - April 19 (Reuters) - Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson, McKesson Corp and Endo Pharmaceutical, resolving the state’s claims that the companies fueled an opioid addiction crisis, the state Attorney General said. (Reporting by Dietrich Knauth)